OK
OnKure Therapeutics, Inc. (OKUR)
NASDAQ·Healthcare·Biotechnology
$5.26
+5.41%
Mkt Cap $46.06M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $15.96M | — | — | -$1.15 | -$0.99 | +13.91% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$1.20 | -$1.09 | +9.17% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$1.23 | -$1.14 | +7.32% | — | — |
| Q2 2025 May 6, 2025 | — | — | — | -$1.32 | -$1.19 | +9.85% | — | — |
| Q1 2025 Mar 10, 2025 | — | — | — | -$0.86 | -$1.37 | -59.30% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.97 | -$1.10 | -13.40% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$1.00 | -$1.60 | -60.00% | — | — |
| Q2 2024 May 7, 2024 | — | — | — | -$0.37 | -$0.25 | +32.43% | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | -$5.78 | -$7.00 | -21.11% | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | -$5.71 | -$1.44 | +74.82% | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | -$5.30 | -$0.61 | +88.43% | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | -$6.04 | -$0.65 | +89.23% | — | — |
| Q1 2023 Mar 27, 2023 | — | — | — | -$5.88 | -$5.60 | +4.83% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$5.72 | -$5.30 | +7.29% | — | — |